EUDA Health Holdings Limited (NASDAQ:EUDA) Sees Significant Drop in Short Interest

EUDA Health Holdings Limited (NASDAQ:EUDA) saw a large decline in short interest during the month of February. As of February 27th, there was short interest totaling 81,625 shares, a decline of 44.0% from the February 12th total of 145,762 shares. Based on an average daily volume of 21,902 shares, the days-to-cover ratio is currently 3.7 days. Currently, 0.2% of the shares of the stock are sold short. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily volume of 21,902 shares, the days-to-cover ratio is currently 3.7 days.

EUDA Health Price Performance

EUDA Health stock traded down $0.01 during trading on Friday, reaching $0.49. 118,432 shares of the company were exchanged, compared to its average volume of 419,053. The stock’s 50 day simple moving average is $1.29 and its two-hundred day simple moving average is $1.99. The company has a market capitalization of $18.54 million, a P/E ratio of -4.09 and a beta of -0.11. EUDA Health has a 52-week low of $0.46 and a 52-week high of $4.30.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Greenridge Global reduced their target price on shares of EUDA Health from $6.00 to $2.75 and set a “buy” rating for the company in a research report on Monday. Weiss Ratings restated a “sell (d)” rating on shares of EUDA Health in a research report on Friday, January 9th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $2.75.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in EUDA Health stock. Citadel Advisors LLC lifted its position in EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 44,631 shares of the company’s stock after purchasing an additional 16,321 shares during the quarter. Citadel Advisors LLC owned about 0.12% of EUDA Health worth $78,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.35% of the company’s stock.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.